REG - Coca-Cola EP PLC - Transactions in Own Shares
I'm LongbridgeAI, I can summarize articles.Coca-Cola Europacific Partners plc announced it repurchased a total of 261,913 ordinary shares between July 6 and July 10, 2026, from Goldman Sachs affiliates on US and London trading venues. These purchases are part of the company's EUR 1 billion share buyback programme initiated in February 2026. The repurchased shares will be cancelled.
RNS Number : 1442M Coca-Cola Europacific Partners plc 13 July 2026
Coca-Cola Europacific Partners plc (the "Company")
Transactions in Own Shares
The Company confirms that from 6 July 2026 up to and including 10 July 2026 it purchased a total of: (i) 185,000 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 76,913 ordinary shares on the London Trading Venues[2]; in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.
The repurchased ordinary shares will be cancelled.
Date | Aggregate number of ordinary shares purchased | Highest price paid (per ordinary share) | Lowest price paid (per ordinary share) | Volume weighted average price | Trading venue |
6 July 2026 | 40,000 | USD 106.9100 | USD 105.4600 | USD 106.0905 | US Trading Venues |
6 July 2026 | 12,000 | GBP 80.5000 | GBP 79.0000 | GBP 79.5396 | London Stock Exchange |
7 July 2026 | 45,000 | USD 109.3700 | USD 106.0500 | USD 107.6427 | US Trading Venues |
7 July 2026 | 14,923 | GBP 81.8000 | GBP 79.9500 | GBP 80.9267 | London Stock Exchange |
8 July 2026 | 35,000 | USD 107.2900 | USD 105.6200 | USD 106.5214 | US Trading Venues |
8 July 2026 | 20,000 | GBP 80.3000 | GBP 79.3500 | GBP 79.9034 | London Stock Exchange |
9 July 2026 | 30,000 | USD 105.2700 | USD 104.1800 | USD 104.6795 | US Trading Venues |
9 July 2026 | 14,990 | GBP 78.5500 | GBP 77.8500 | GBP 78.1920 | London Stock Exchange |
10 July 2026 | 35,000 | USD 106.5600 | USD 105.1200 | USD 105.9959 | US Trading Venues |
10 July 2026 | 15,000 | GBP 79.5000 | GBP 78.2500 | GBP 78.8244 | London Stock Exchange |
The purchases form part of the Company's share buyback programme announced on 17 February 2026 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).
This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at
http://www.rns-pdf.londonstockexchange.com/rns/1442M_1-2026-7-13.pdf
CONTACTS
- Company SecretariatSvetlana Walkersvetlana.walker@ccep.com
- Investor RelationsSarah Willettsarah.willett@ccep.com
- Media RelationsShanna Wendtmediaenquiries@ccep.com
ABOUT CCEP
Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.
We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.
The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).
For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn
[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.
[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END POSAKNBBQBKDKOD